Confocal Laser Endomicroscopy Based Diet in Functional Dyspepsia
NCT05666154 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2024-07-03
Summary
After a thorough baseline evaluation, functional dyspepsia (FD) patients will be exposed to nutrients while undergoing confocal laser endomicroscopy (CLE). Patients presenting an acute mucosal reaction upon nutrient exposure will be instructed to exclude their respective trigger nutrient or a nutrient without mucosal reaction (=sham diet) from their diet for 4 weeks in a randomized, blinded crossover fashion.
The aim of the trial is to assess the symptomatic response to the targeted diet and further elucidate mechanisms underlying the acute mucosal reactions observed in CLE upon nutrient exposure.
Conditions
- Functional Dyspepsia
Interventions
- OTHER
-
Real diet
Diet excluding either trigger nutrient in a blinded crossover fashion (CLE positive individuals with identified trigger)
- OTHER
-
Sham diet
Diet excluding either sham nutrient in a blinded crossover fashion (CLE positive individuals with identified trigger) or wheat and soy in a blinded crossover fashion (CLE negative individuals without identified trigger)
- OTHER
-
Wheat exclusion diet
Diet excluding wheat in a blinded crossover fashion (CLE negative individuals without identified trigger)
- OTHER
-
Soy exclusion diet
Diet excluding soy in a blinded crossover fashion (CLE negative individuals without identified trigger)
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-05
- Primary Completion
- 2025-07-31
- Completion
- 2025-08-31
Countries
- Belgium
Study Locations
More Related Trials
-
Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia
NCT03004118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effect of Secretin in Functional Dyspepsia and Healthy Subjects
NCT03617861 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mucosal Barrier Defects in Functional Dyspepsia by Confocal Laser Endomicroscopy
NCT01006642 ·Status: UNKNOWN
-
PEA in Functional Dyspepsia
NCT05877781 ·Status: RECRUITING ·Phase: NA
-
Responses to a Comfort Meal in Functional Dyspepsia
NCT04722419 ·Status: COMPLETED ·Phase: NA
-
Functional Dyspepsia Microbiome Study
NCT02340312 ·Status: COMPLETED
-
Mast Cells in Acid-induced Intestinal Permeability
NCT02664051 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of Rikkunshito on Gastric Accommodation and Nutrient Volume Tolerance in Functional Dyspepsia
NCT03856294 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
NCT05513040 ·Status: RECRUITING
-
Budesonide as a Treatment for Functional Dyspepsia
NCT06841406 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
NCT02875678 ·Status: TERMINATED ·Phase: PHASE1
-
Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by Endomicroscopy
NCT02465996 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients
NCT03844100 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Advancing Nutritional Science for Children With Functional Dyspepsia
NCT04053049 ·Status: COMPLETED ·Phase: NA
-
Intestinal Permeability in Children/Adolescents With Functional Dyspepsia
NCT00363597 ·Status: COMPLETED
-
Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method
NCT02151708 ·Status: UNKNOWN ·Phase: NA
-
ESM in Functional Dyspepsia
NCT04204421 ·Status: COMPLETED ·Phase: NA
-
Association Between Luminal Bile Salt Content and Duodenal Mucosal Integrity in Functional Dyspepsia
NCT03003234 ·Status: COMPLETED ·Phase: NA
-
Identification of Nutrient Receptors Gastrointestinal Tract
NCT02051881 ·Status: COMPLETED ·Phase: NA
-
Primary Care dySpEpsia rikkuNshiTo
NCT06482671 ·Status: RECRUITING ·Phase: PHASE3
-
Postprandial Distress Itopride Cohort Trial
NCT07165301 ·Status: NOT_YET_RECRUITING
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Abdominothoracic Muscular Tone in Functional Dyspepsia
NCT05417204 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
NCT06931223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Treatment of Functional Dyspepsia With Acupuncture
NCT00786214 ·Status: COMPLETED ·Phase: NA